SEARCH

SEARCH BY CITATION

References

  • Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R. & Sultan, C. (1982) Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology, 51, 189199.
  • Born, T.L., Thomassen, E., Bird, T.A. & Sims, J.E. (1998) Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling. Journal of Biological Chemistry, 273, 2944529450.
  • Boultwood, J. & Fidler, C. (1995) Chromosomal deletions in myelodysplasia. Leukemia & Lymphoma, 17, 7178.
  • Boultwood, J., Lewis, S. & Wainscoat, J.S. (1994) The 5q-syndrome. Blood, 84, 32533260.
  • Boultwood, J., Fidler, C., Strickson, A.J., Watkins, F., Gama, S., Kearney, L., Tosi, S., Kasprzyk, A., Cheng, J.F., Jaju, R.J. & Wainscoat, J.S. (2002) Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome. Blood, 99, 46384641.
  • Boyum, A. (1968) Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scandinavian Journal of Clinical & Laboratory Investigation Supplement, 97, 7789.
  • van Dam, H. & Castellazzi, M. (2001) Distinct roles of Jun:Fos and Jun:ATF dimers in oncogenesis. Oncogene, 20, 24532464.
  • Di Bacco, A. & Gill, G. (2003) The secreted glycoprotein CREG inhibits cell growth dependent on the mannose-6-phosphate/insulin-like growth factor II receptor. Oncogene, 22, 54365445.
  • Fenaux, P. (2001) Chromosome and molecular abnormalities in myelodysplastic syndromes. International Journal of Hematology, 73, 429437.
  • Fosslien, E. (2001) Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis. Annals of Clinical and Laboratory Science, 31, 325348.
  • Gasparini, G., Longo, R., Sarmiento, R. & Morabito, A. (2003) Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents? Lancet Oncology, 4, 605615.
  • Gibbons, R.J., Pellagatti, A., Garrick, D., Wood, W.G., Malik, N., Ayyub, H., Langford, C., Boultwood, J., Wainscoat, J.S. & Higgs, D.R. (2003) Identification of acquired somatic mutations in the gene encoding chromatin-remodeling factor ATRX in the alpha-thalassemia myelodysplasia syndrome (ATMDS). Nature Genetics, 34, 446449.
  • Giles, F.J., Kantarjian, H.M., Bekele, B.N., Cortes, J.E., Faderl, S., Thomas, D.A., Manshouri, T., Rogers, A., Keating, M.J., Talpaz, M., O'Brien, S. & Albitar, M. (2002) Bone marrow cyclooxygenase-2 levels are elevated in chronic-phase chronic myeloid leukaemia and are associated with reduced survival. British Journal of Haematology, 119, 3845.
  • Golub, T.R., Slonim, D.K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J.P., Coller, H., Loh, M.L., Downing, J.R., Caligiuri, M.A., Bloomfield, C.D. & Lander, E.S. (1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science, 286, 531537.
  • Greenberg, P., Cox, C., LeBeau, M.M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., Ohyashiki, K., Toyama, K., Aul, C., Mufti, G. & Bennett, J. (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood, 89, 20792088.
  • Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Muller-Hermelink, H.K., Vardiman, J., Lister, T.A. & Bloomfield, C.D. (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November1997. Journal of Clinical Oncology, 17, 38353849.
  • Heaney, M.L. & Golde, D.W. (1999) Myelodysplasia. New England Journal of Medicine, 340, 16491660.
  • Heid, C.A., Stevens, J., Livak, K.J. & Williams, P.M. (1996) Real time quantitative PCR. Genome Research, 6, 986994.
  • Hofmann, W.K., de Vos, S., Komor, M., Hoelzer, D., Wachsman, W. & Koeffler, H.P. (2002) Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow. Blood, 100, 35533560.
  • Holland, P.M., Abramson, R.D., Watson, R. & Gelfand, D.H. (1991) Detection of specific polymerase chain reaction product by utilizing the 5′–3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proceedings of the National Academy of Sciences of the United States America, 88, 72767280.
  • Jenkinson, C.P., Grody, W.W. & Cederbaum, S.D. (1996) Comparative properties of arginases. Comparative Biochemistry and Physiology B-Biochemistry & Molecular Biology, 114, 107132.
  • Johansson, B., Mertens, F. & Mitelman, F. (1993) Cytogenetic deletion maps of hematologic neoplasms: circumstantial evidence for tumor suppressor loci. Genes Chromosomes & Cancer, 8, 205218.
  • Klippel, S., Strunck, E., Temerinac, S., Bench, A.J., Meinhardt, G., Mohr, U., Leichtle, R., Green, A.R., Griesshammer, M., Heimpel, H. & Pahl, H.L. (2003) Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosis. Blood, 102, 35693574.
  • Leung, B.P., Culshaw, S., Gracie, J.A., Hunter, D., Canetti, C.A., Campbell, C., Cunha, F., Liew, F.Y. & McInnes, I.B. (2001) A role for IL-18 in neutrophil activation. Journal of Immunology, 167, 28792886.
  • Lord, K.A., Abdollahi, A., Hoffman-Liebermann, B. & Liebermann, D.A. (1993) Proto-oncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation. Molecular and Cell Biology, 13, 841851.
  • Margalit, O., Eisenbach, L., Amariglio, N., Kaminski, N., Harmelin, A., Pfeffer, R., Shohat, M., Rechavi, G. & Berger, R. (2003) Overexpression of a set of genes, including WISP-1, common to pulmonary metastases of both mouse D122 Lewis lung carcinoma and B16-F10.9 melanoma cell lines. British Journal of Cancer, 89, 314319.
  • Mazzone, A., Porta, C., Fossati, G., Gritti, D., Mazzucchelli, I. & Ricevuti, G. (1996) Granulocyte dysplasia and dysfunction, and CD11/CD18 defects in myelodysplastic syndromes. Leukemia & Lymphoma, 23, 267275.
  • Miyazato, A., Ueno, S., Ohmine, K., Ueda, M., Yoshida, K., Yamashita, Y., Kaneko, T., Mori, M., Kirito, K., Toshima, M., Nakamura, Y., Saito, K., Kano, Y., Furusawa, S., Ozawa, K. & Mano, H. (2001) Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction. Blood, 98, 422427.
  • Napolitano, M., Modi, W.S., Cevario, S.J., Gnarra, J.R., Seuanez, H.N. & Leonard, W.J. (1991) The gene encoding the Act-2 cytokine. Genomic structure, HTLV-I/Tax responsiveness of 5’ upstream sequences, and chromosomal localization. Journal of Biological Chemistry, 266, 1753117536.
  • Ohsaka, A., Saionji, K., Igari, J., Watanabe, N., Iwabuchi, K. & Nagaoka, I. (1997) Altered surface expression of effector cell molecules on neutrophils in myelodysplastic syndromes. British Journal of Haematology, 98, 108113.
  • Olney, H.J. & Le Beau, M.M. (2001) The cytogenetics of myelodysplastic syndromes. Best Practice & Research Clinical Haematology, 14, 479495.
  • Oxford, G. & Theodorescu, D. (2003) Ras superfamily monomeric G proteins in carcinoma cell motility. Cancer Letters, 189, 117128.
  • Pellagatti, A., Vetrie, D., Langford, C.F., Gama, S., Eagleton, H., Wainscoat, J.S. & Boultwood, J. (2003) Gene expression profiling in polycythemia vera using cDNA microarray technology. Cancer Research, 63, 39403944.
  • Singh, R., Pervin, S., Karimi, A., Cederbaum, S. & Chaudhuri, G. (2000) Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells. Cancer Research, 60, 33053312.
  • Steensma, D.P. & Tefferi, A. (2003) The myelodysplastic syndrome(s): a perspective and review highlighting current controversies. Leukemia Research, 27, 95120.
  • Van den Berghe, H., Vermaelen, K., Mecucci, C., Barbieri, D. & Tricot, G. (1985) The 5q-anomaly. Cancer Genetics and Cytogenetics, 17, 189255.
  • Van Gelder, R.N., von Zastrow, M.E., Yool, A., Dement, W.C., Barchas, J.D. & Eberwine, J.H. (1990) Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proceedings of the National Academy of Sciences of the USA, 87, 16631667.
  • Waddington, S.N., Mosley, K., Cook, H.T., Tam, F.W. & Cattell, V. (1998) Arginase AI is upregulated in acute immune complex-induced inflammation. Biochemistry and Biophysics Research Communications, 247, 8487.
  • Watanabe, O., Shimizu, T., Imamura, H., Kinoshita, J., Utada, Y., Okabe, T., Kimura, K., Hirano, A., Yoshimatsu, K., Aiba, M. & Ogawa, K. (2003) Expression of cyclooxygenase-2 in malignant and benign breast tumors. Anticancer Research, 23, 32153221.
  • Yao, R., Wang, Y., Lubet, R.A. & You, M. (2002) Differentially expressed genes associated with mouse lung tumor progression. Oncogene, 21, 58145821.